What We're Reading: Page 92
Industry reads hand-picked by our editors
Aug 23, 2023
Aug 22, 2023
Aug 21, 2023
-
C&EN
The challenge of treating childhood brain cancers
-
MIT Technology Review
A chemo drug shortage shows the vulnerability of the healthcare supply chains
-
BioSpace
Roche, Exelixis’ Drug Combo Bounces Back with Late-Stage Prostate Cancer Win
-
The Wall Street Journal
The Booming Business of American Anxiety
Aug 18, 2023
-
The Washington Post
U.S eyes battle with drug giants over 10 costly medications for seniors
-
The Wall Street Journal
America’s Obsession With Weight-Loss Drugs Is Affecting the Economy of Denmark
-
Bloomberg
Pentagon Forms Council to Assess Biothreats, Coordinate Response
Aug 17, 2023
-
The Wall Street Journal
A Big Health Insurer Is Ripping Up the Playbook on Drug Pricing
-
The New York Times
We Know Where New Weight Loss Drugs Came From, but Not Why They Work
-
Nature
Thousands of scientists are cutting back on Twitter, seeding angst and uncertainty
-
NBC News
Price gouging of cancer drugs in short supply hits some hospitals hard
Aug 16, 2023
Aug 15, 2023
-
The Wall Street Journal
He Developed a Drug to Treat Psoriasis. He Also Had the Disease Himself.
-
Reuters
What happens when a $2 million gene therapy is not enough
-
Axios
Venture capitalist’s cancer scare highlights debate over full-body scans
-
FirstWord Pharma
A decade after rejection, Delcath snags FDA approval of drug-device combo
Previous
